- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 23.07. | Affinia Therapeutics receives FDA orphan drug designation for AFTX-201 | ||
| 23.07. | Evogene and ELEO to develop new oral PCSK9 inhibitors | ||
| 23.07. | Crystalys banks $130m to progress gout drug, plan for commercial readiness | ||
| 22.07. | US generic tariff reprieve on the rocks as Trump proposes 100% rate in 2028 | ||
| 22.07. | Kyowa Kirin EMEA's Crysvita approved by EC for infants with XLH | ||
| 22.07. | Cellares and Papillon partner for PPL-001 manufacturing automation | ||
| 21.07. | Novo sues Lilly after alleged misleading and false advertising campaign | ||
| 21.07. | Novartis Q2 profits recover as revenue mantle passes to newer medicines | ||
| 21.07. | Bristol Myers, NVIDIA join forces to build life science's 'most powerful' AI factory | ||
| 21.07. | EMA's CHMP grants PRIME status to AbelZeta's C-CAR168 | ||
| 21.07. | Halozyme and Incyte sign licence agreement for INCA033989 formulations | ||
| 20.07. | Novartis and Takeda drugs gain rare blood cancer routine use on NHS | ||
| 20.07. | Samsung Biologics to acquire PolyPeptide in $1.81bn cash deal | ||
| 20.07. | UK biotech financing continues recovery trajectory on five-year Q2 high | ||
| 20.07. | Aptar unveils framework for injectable drug delivery systems | ||
| 17.07. | Bayer's heart failure drug bound for NHS on NICE recommendation | ||
| 17.07. | FDA grants traditional approval to Novartis' Fabhalta for IgAN | ||
| 17.07. | MSD wins FDA approval for cholesterol pill to help plug Keytruda void | ||
| 17.07. | JCVI issues recommendation on adolescent MenB vaccination in UK | ||
| 16.07. | UK commits to pharma IP protection in Swiss trade deal | ||
| 16.07. | Novo secures European approval for oral Wegovy to extend lead over Lilly | ||
| 16.07. | Lilly enters psychedelic realm through $2.8bn AtaiBeckley takeover | ||
| 16.07. | Big pharma-backed AdvanCell pockets $315m to progress RLT to Phase III | ||
| 16.07. | Telix opens radiopharmaceutical facility in Australia for cancer treatment | ||
| 16.07. | Harbour BioMed and Kelun-Biotech receive China IND approval for asthma therapy |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.